Exelixis EXEL
NASDAQ EXEL
$59.02 -0.11 (-0.19%)
As of: Sep 4, 2026 · 3:59 PM EDT

Exelixis (EXEL) Other Accumulated Expenses (2010 - 2026)

Exelixis (EXEL) posted quarterly Other Accumulated Expenses of $100.3 million for Q2 2026, down 20.12% year-over-year from $125.6 million in Q2 2025, and down 20.02% quarter-over-quarter from $125.4 million in Q1 2026.

Analysis

Exelixis (EXEL) Other Accumulated Expenses (2010 - 2026) Analysis & Trends

Exelixis' Other Accumulated Expenses history runs 17 years deep, the most recent figure standing at $100.3 million for Q2 2026.

  • In Q2 2026, Other Accumulated Expenses fell 20.12% year-over-year to $100.3 million; the TTM figure through Apr 2026 stood at $100.3 million (down 20.12% YoY), while the FY2026 annual figure was $125.4 million, up 31.96% from the prior year.
  • Other Accumulated Expenses for Q2 2026 stood at $100.3 million, down from $125.4 million in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $125.6 million in Q2 2025, with the low at $63.7 million in Q2 2022.
  • The 5-year median for Other Accumulated Expenses is $101.4 million (2025), against an average of $99.0 million.
  • The sharpest annual moves came in 2023 and 2024: Other Accumulated Expenses soared 55.39% in 2023, then dropped 23.1% in 2024.
  • Exelixis' Other Accumulated Expenses stood at $78.9 million in 2022, then jumped by 37.37% to $108.4 million in 2023, then decreased by 11.71% to $95.7 million in 2024, then advanced by 9.3% to $104.6 million in 2025, then retreated by 4.14% to $100.3 million in 2026.
  • Business Quant data shows EXEL's Other Accumulated Expenses at $100.3 million in Q2 2026, $125.4 million in Q1 2026, and $104.6 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Exelixis 14.81 Bn 13.97 Bn 608.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 3, 2026 102.66 Mn
Apr 3, 2026 100.29 Mn
Jan 2, 2026 125.38 Mn
Oct 3, 2025 104.62 Mn
Jul 4, 2025 101.37 Mn
Apr 4, 2025 125.55 Mn
Jan 3, 2025 95.01 Mn
Sep 27, 2024 95.72 Mn
Jun 28, 2024 103.24 Mn
Mar 29, 2024 104.29 Mn
Dec 29, 2023 108.42 Mn
Sep 29, 2023 124.48 Mn
Jun 30, 2023 110.70 Mn
Mar 31, 2023 89.49 Mn
Dec 30, 2022 78.92 Mn
Sep 30, 2022 80.11 Mn
Jul 1, 2022 72.57 Mn
Apr 1, 2022 63.65 Mn
Dec 31, 2021 53.37 Mn
Oct 1, 2021 54.75 Mn